Plasmin-platelet interaction involves cleavage of functional thrombin receptor

American Journal of Physiology - Cell Physiology

Volumn 271, Issue 1 40-1, 1996, Pages

  Kimura, Masayuki ^a   Andersen, Thomas T ^b   Fenton II, John W ^b   Bahou, Wadie F ^b   Aviv, Abraham ^b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

cytosolic calcium; serine protease; tethered peptide

Indexed keywords

CALCIUM ION; PLASMIN; RECEPTOR ANTIBODY; RECEPTOR PROTEIN; SYNTHETIC PEPTIDE; THROMBIN; THROMBIN RECEPTOR; THROMBIN RECEPTOR ACTIVATING PEPTIDE;

AMINO ACID SEQUENCE; ANTIBODY PRODUCTION; ANTIGEN BINDING; ARTICLE; BLOOD SAMPLING; DOSE TIME EFFECT RELATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INTERNALIZATION; MASS SPECTROMETRY; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; THROMBOCYTE; THROMBOCYTE ACTIVATION;

EID: 0029779961     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.1996.271.1.c54     Document Type: Article

References (21)

1. Bahou, W. F., B. S. Coller, C. L. Potter, K. J. Norton, J. L. Kutok, and M. S. Goligorsky. The thrombin receptor extracellular domain contains sites crucial for peptide ligand-induced activation. J. Clin. Invest. 91: 1405-1413, 1993.
2. Bidlingmeyer, B. A., S. A. Cohen, and T. L. Tarvin. Rapid analysis of amino acids using pre-column derivitization. J. Chromatogr. 336: 93-104, 1984.
3. Brass, L. F., S. Pizarro, M. Ahuja, E. Belmonte, N. Blan-chard, J. M. Stadel, and J. A. Hoxie. Changes in the structure and function of the human thrombin receptor during receptor activation, internalization, and recycling. J. Biol. Chem. 269: 2943-2952, 1994.
4. Coughlin, S. R., T. H. Vu, D. T. Hung, and V. I. Wheaton. Characterization of a functional thrombin receptor. Issues and opportunities. J. Clin. Invest. 89: 351-355, 1992.
5. Cramer, E. M., H. Lu, J. P. Caen, C. Soria, M. C. Berndt, and D. Tenza. Differential redistribution of platelet glycoproteins Ib and IIb-IIIa after plasmin stimulation. Blood 77: 694-699, 1991.
6. Ishii, K., L. Hein, B. Kobilka, and S. R. Coughlin. Kinetics of thrombin receptor cleavage on intact cells. Relation to signaling. J. Biol. Chem. 268: 9780-9786, 1993.
7. 2+ response in human platelets. Am. J. Physiol. 267 (Cell Physiol. 36): C1543-C1552, 1994.
8. Merrifield, R. B. Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. J. Am. Chem. Soc. 85: 2149-2154, 1963.
9. Mirza, H., V. Yatsula, and W. Bahou. The proteinase activated receptor-2 (PAR-2) mediates mitogenic responses in human vascular endothelial cells: molecular characterization and evidence for functional coupling to the thrombin receptor (TR). J. Clin. Invest. 97: 1705-1714, 1996.
10. Nakamura, K., M. Kimura, J. W. Fenton II, T. T. Andersen, and A. Aviv. Duality of plasmin effect on cytosolic free calcium in human platelet. Am. J. Physiol. 268 (Cell Physiol. 37): C958-C967, 1995.
11. Norton, K. J., R. M. Scarborough, J. L. Kutok, M.-A. Escobedo, L. Nannizzi, and B. S. Coller. Immunologic analysis of the cloned platelet thrombin receptor activation mechanism: evidence supporting receptor cleavage, release of the N-terminal peptide, and insertion of the tethered ligand into a protected environment. Blood 82: 2125-2136, 1993.
12. Penny, W. F., and J. A. Ware. Platelet activation and subsequent inhibition by plasmin and recombinant tissue-type plasminogen activator. Blood 79: 91-98, 1992.
13. Scarborough, R. M., M. A. Naughton, W. Teng, D. T. Hungs, J. Rose, T. H. Vu, V. I. Wheaton, C. W. Turck, and S. R. Coughlin. Tethered ligand agonist peptides. Structural requirement for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function. J. Biol. Chem. 267: 13146-13149, 1992.
14. Schafer, A. I., and B. Adelman. Plasmin inhibition of platelet function and of arachidonic acid metabolism. J. Clin. Invest. 75: 456-461, 1985.
15. Schafer, A. I., A. K. Maas, J. A. Ware, P. C. Johnson, S. E. Rittenhouse, and E. W. Salzman. Platelet protein phosphorylation, elevation of cytosolic calcium, and inositol phospholipid breakdown in platelet activation induced by plasmin. J. Clin. Invest. 78: 73-79, 1986.
16. Schafer, A. I., G. B. Zavoico, J. Loscalzo, and A. K. Maas. Synergistic inhibition of platelet activation by plasmin and prostaglandin 12. Blood 69: 1504-1507, 1987.
17. Strydom, D. J., T. T. Andersen, I. Apostol, J. W. Fox, R. J. Paxton, and J. W. Crabb. Cysteine and Tryptophan Amino Acid Analysis of ABRF92-AAA. Techniques in Protein Chemistry IV. San Diego, CA: Academic, 1993, p. 279-288.
18. Tam, J. P., W. F. Heath, and R. B. Merrifield. SN2 deprotection of synthetic peptides with a low concentration of HF in dimethyl sulfide: evidence and application in peptide synthesis. J. Am. Chem. Soc. 105: 6442-6455, 1983.
19. Vouret-Craviari, V., D. Grail, J.-C. Chambard, U. B. Rasmussen, J. Pouyssegur, and E. V. Obberghen-Schilling. Posttranslational and activation-dependent modifications of the G protein-coupled thrombin receptor. J. Biol. Chem. 270: 8367-8372, 1995.
20. Vu, T. H., D. T. Hung, V. I. Wheaton, and S. R. Coughlin. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64: 1057-1068, 1991.
21. Vu, T. H., V. I. Wheaton, D. T. Hung, I. Charo, and S. R. Coughlin. Domains specifying thrombin-receptor interaction. Nature Lond. 353: 674-677, 1991.